Al-Rashidi Sultan H
Department of Ophthalmology, College of Medicine, Qassim University, Buraidah, Al-Qassim, Saudi Arabia.
J Ophthalmic Vis Res. 2019 Jan-Mar;14(1):27-31. doi: 10.4103/jovr.jovr_244_17.
To review the management outcomes of black diaphragm intraocular (BDI) lens implantation in Arab patients with aniridia.
Patients with aniridia undergone BDI lens implantation at our institution between 2013 and 2014 were included. Uncorrected visual acuity (UCVA), manifest refraction, and best-corrected visual acuity (BCVA) were evaluated before and 6 months and yearly after BDI lens implant surgery until the last visit. Intra- and postoperative complications were noted.
Our series comprised 14 patients (8 males) with aniridia. The median duration of follow-up was 30 months (25% quartile). Ocular parameters, refractive status, and vison were all significantly improved at the last follow-up compared to the preoperative values ( < 0.05 for all comparisons). All patients reported a significant decrease in photophobia and glare. Postoperatively, 11 eyes (78%) gained 2 or more lines of UCVA. At the last follow-up, BCVA increased by 2 or more lines in all cases. Early postoperative complications included main wound leakage (one eye) and anterior chamber hyphema (one eye). Late (≥6 months) complications included corneal decompensation (one eye), failed penetrating keratoplasty graft (2 eyes), and subluxation of a scleral fixated BDI lens (one eye). Surgical interventions performed to manage complications included penetrating keratoplasty in 2 eyes with corneal decompensation and failed graft (one each), and re-suturing of a subluxated intraocular lens (one eye).
BDI lenses seem to be a safe and effective iris prosthetic with intraocular lens combination surgery for patients with congenital or traumatic aniridia. Periodic evaluation and prompt management of complications are recommended.
回顾阿拉伯无虹膜患者植入黑色人工瞳孔人工晶状体(BDI)的治疗效果。
纳入2013年至2014年在我院接受BDI人工晶状体植入的无虹膜患者。在BDI人工晶状体植入手术前、术后6个月及每年进行一次未矫正视力(UCVA)、显验光和最佳矫正视力(BCVA)评估,直至最后一次随访。记录术中及术后并发症。
我们的系列研究包括14例(8例男性)无虹膜患者。中位随访时间为30个月(四分位数间距为25%)。与术前值相比,末次随访时的眼部参数、屈光状态和视力均有显著改善(所有比较均P<0.05)。所有患者均报告畏光和眩光明显减轻。术后,11只眼(78%)的UCVA提高了2行或更多。在末次随访时,所有病例的BCVA均提高了2行或更多。术后早期并发症包括主切口渗漏(1只眼)和前房积血(1只眼)。晚期(≥6个月)并发症包括角膜失代偿(1只眼)、穿透性角膜移植术植片失败(2只眼)和巩膜固定BDI人工晶状体半脱位(1只眼)。为处理并发症而进行的手术干预包括对2只角膜失代偿和植片失败的眼睛(各1只)进行穿透性角膜移植术,以及对1只半脱位的人工晶状体进行重新缝合。
对于先天性或外伤性无虹膜患者,BDI人工晶状体似乎是一种安全有效的虹膜假体与人工晶状体联合手术。建议定期评估并及时处理并发症。